IRIS
MANCARDI, GIOVANNI LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 53.734
AS - Asia 1.748
SA - Sud America 300
NA - Nord America 189
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 56.024
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 53.666
SG - Singapore 810
CN - Cina 452
VN - Vietnam 294
BR - Brasile 192
US - Stati Uniti d'America 138
HK - Hong Kong 69
AR - Argentina 50
MX - Messico 38
ID - Indonesia 29
IQ - Iraq 20
EC - Ecuador 19
CO - Colombia 12
IN - India 11
BD - Bangladesh 10
RU - Federazione Russa 10
ZA - Sudafrica 10
UA - Ucraina 8
VE - Venezuela 8
PY - Paraguay 7
TN - Tunisia 7
DZ - Algeria 6
JO - Giordania 6
DE - Germania 5
EG - Egitto 5
GB - Regno Unito 5
LB - Libano 5
PK - Pakistan 5
CL - Cile 4
MA - Marocco 4
NP - Nepal 4
PE - Perù 4
PL - Polonia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AT - Austria 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
FR - Francia 3
HR - Croazia 3
IL - Israele 3
MN - Mongolia 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GH - Ghana 2
HT - Haiti 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
MU - Mauritius 2
NL - Olanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SN - Senegal 2
SO - Somalia 2
TH - Thailandia 2
TR - Turchia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CA - Canada 1
CD - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ES - Italia 1
GN - Guinea 1
GT - Guatemala 1
IE - Irlanda 1
IR - Iran 1
IS - Islanda 1
JP - Giappone 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LU - Lussemburgo 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 56.024
Salva come PNG Salva come JPEG
Città #
Genova 35.457
Genoa 11.084
Rapallo 4.076
Vado Ligure 2.943
Singapore 389
Beijing 137
Ho Chi Minh City 103
Bordighera 80
Hanoi 76
Hong Kong 67
Ashburn 56
Mexico City 25
Tianjin 23
São Paulo 21
New York 17
Haiphong 14
Biên Hòa 12
Da Nang 12
Los Angeles 8
San Jose 8
Orem 7
Rome 7
Baghdad 6
Jakarta 6
Johannesburg 6
Ninh Bình 6
Amman 5
Contagem 5
Guayaquil 5
Hải Dương 5
Quảng Ngãi 5
Thái Bình 5
Belo Horizonte 4
Bắc Ninh 4
Changsha 4
Curitiba 4
Phoenix 4
Tashkent 4
Uberlândia 4
Warsaw 4
Atlanta 3
Bogotá 3
Brasília 3
Brno 3
Buenos Aires 3
Can Tho 3
Chennai 3
Delhi 3
Erbil 3
Frankfurt am Main 3
Isidro Casanova 3
Karachi 3
Karbala 3
Maracaibo 3
Nantong 3
Nova Iguaçu 3
Phủ Lý 3
Poplar 3
Quito 3
Rio de Janeiro 3
Santo André 3
Thái Nguyên 3
Ulan Bator 3
Addis Ababa 2
Agadir 2
Al Ain City 2
Banjar Badung 2
Bari 2
Beirut 2
Brooklyn 2
Bắc Giang 2
Cairo 2
Cantalupo Ligure 2
Cape Town 2
Caracas 2
Coro 2
Cuenca 2
Córdoba 2
Dakar 2
Dallas 2
Denver 2
Fighiera 2
Florianópolis 2
Franca 2
Ha Kwai Chung 2
Hangzhou 2
Houston 2
Itapevi 2
Itaquaquecetuba 2
Jeddah 2
Joinville 2
Lanús 2
Lima 2
Loja 2
Manaus 2
Milan 2
Minsk 2
Montevideo 2
Nanjing 2
Nuremberg 2
Totale 54.851
Salva come PNG Salva come JPEG
Nome #
Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS 241
An updated Italian normative dataset for the Stroop color word test (SCWT) 230
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy 227
Finger motor performance as a new quantitative clinical endpoint in multiple sclerosis 220
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. 220
Dysimmune mononeuropathies: A diagnosis not to be missed 215
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 214
A normative study of the Italian printed word version of the free and cued selective reminding test 211
Neural correlates of ankle movements during different motor tasks: A feasibility study 206
Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis 202
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. 201
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 197
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. 197
Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. 196
Early switch to fingolimod may decrease the risk of disease recurrence after natalizumab interruption 194
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. 192
Basal ganglia are active during motor performance recovery after a demanding motor task. 192
Fast course ALS presenting with vocal cord paralysis: clinical features, bioinformatic and modelling analysis of the novel SOD1 Gly147Ser mutation. 188
Clinical epidemiology of ALS in Liguria, Italy. 187
Granulocyte-macrophage colony-stimulating factor activity in cerebrospinal fluid 186
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 185
Acute disseminated encephalomyelitis with severe neurological outcomes following virosomal seasonal influenza vaccine 185
Neural correlates of lower limbs proprioception: An fMRI study of foot position matching 185
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. 183
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 181
A restricted T cell response to myelin basic protein (MBP) is stable in multiple sclerosis (MS) patients. 181
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. 181
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 180
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. 179
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification. 178
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 178
Different MRI patterns in MS worsening after stopping fingolimod 178
Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. 174
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 174
In vitro VLA-4 blockade results in an impaired NK cell-mediated immune surveillance against melanoma 174
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. 174
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 173
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 173
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 172
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study. 172
The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. 172
A New App for At-Home Cognitive Training: Description and Pilot Testing on Patients with Multiple Sclerosis 171
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 171
An engineered glove for investigating the neural correlates of finger movements using functional magnetic resonance imaging 171
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 170
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. 170
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 169
Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results. 169
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 169
Direct immunofluorescence in sural nerve biopsies. 168
Evidence for aerobic ATP synthesis in isolated myelin vesicles 168
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 165
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. 165
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 163
GFAP expression of human Schwann cells in tissue culture. 163
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease 163
Screening, diagnosis, and management of obstructive sleep apnea in dangerous-goods truck drivers: to be aware or not? 163
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 163
A patient with multiple sclerosis and Down's syndrome with a rare paroxysmal symptom at onset. 162
A prospective study of acute idiopathic neuropathy II antecedent events. 162
Analisi e studio longitudinale della fine specificità di linee linfocitarie T specifiche per la proteina basica della mielina (MBP) in pazienti con sclerosi multipla e in controlli normali. 162
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 162
OXCARBAZEPINE FOR TREATING PAROXYSMAL PAINFUL SYMPTOMS IN MULTIPLE SCLEROSIS: A PILOT STUDY. 161
Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients. 161
Demyelination and axonal damage in a non-human primate model of multiple sclerosis. 161
Low intensity lympho-ablative regimen followed by autologous hematopoietic stem cell transplantation in severe forms of multiple sclerosis: A MRI-based clinical study. 161
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial. 161
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 161
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 161
123I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies 161
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 160
Neurological research in Italy in 2003 and 2004. 159
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 159
Three years of experience: the Italian registry and safety data update 159
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 158
Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks 157
Autologous stem cell transplantation for severe autoimmune diseases: a 10-year experience. 157
Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1 157
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 157
Upper limb motor training based on task-oriented exercises induces functional brain reorganization in patients with multiple sclerosis 157
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis. 156
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 156
Subclinical motor impairment assessed with an engineered glove correlates with magnetic resonance imaging tissue damage in radiologically isolated syndrome 156
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis. 155
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 155
'Apraxia' of eye opening in idiopathic Parkinson's disease. 155
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 155
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. 155
Mesenchymal stem cells for multiple sclerosis: does neural differentiation really matter? 155
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 155
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 155
Delirium in the acute phase after stroke: comparison between methods of detection 154
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. 153
Early electophysiological changes in transgenic rat model of charcot-marie-tooth. 153
Primary varicella zoster infection associated with fingolimod treatment. 153
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 153
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 152
Schwann cell expression of HLA-DR antigen in peripheral neuropathies. 152
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 152
Accumulation of clonally-related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients 151
Totale 17.286
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.327
article - articoli 158.137
book - libri 780
conference - conferenze 13.152
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.258
Totale 346.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.969 0 0 0 0 0 256 196 348 291 384 233 261
2021/20225.493 165 399 656 695 170 292 287 1.250 217 494 152 716
2022/20234.881 491 396 58 467 803 858 20 370 854 27 467 70
2023/20242.539 154 340 64 283 190 521 201 152 131 35 122 346
2024/20257.294 248 564 249 465 989 778 631 1.134 324 335 627 950
2025/20265.875 1.593 388 745 1.100 1.688 361 0 0 0 0 0 0
Totale 56.582